This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis 2013; 58: e44–e100.
Shigayeva A, Rudnick W, Green K, Chen DK, Demczuk W, Gold WL et al. Invasive pneumococcal disease among immunocompromised persons: implications for vaccination programs. Clin Infect Dis 2016; 62: 139–147.
Teh BW, Harrison SJ, Pellegrini M, Thursky KA, Worth LJ, Slavin MA . Changing treatment paradigms for patients with plasma cell myeloma: impact upon immune determinants of infection. Blood Rev 2014; 28: 75–86.
Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009; 15: 1143–1238.
Ariza-Heredia EJ, Gulbis AM, Stolar KR, Kebriaei P, Shah DP, McConn KK et al. Vaccination guidelines after hematopoietic stem cell transplantation: practitioners' knowledge, attitudes, and gap between guidelines and clinical practice. Transplant Infect Dis 2014; 16: 878–886.
Kumar D, Humar A, Plevneshi A, Siegal D, Franke N, Green K et al. Invasive pneumococcal disease in adult hematopoietic stem cell transplant recipients: a decade of prospective population-based surveillance. Bone Marrow Transplant 2008; 41: 743–747.
Australian Technical Advisory Group on Immunisation (ATAGI). The Australian Immunisation Handbook, 10th edn. Australian Government Department of Health: Canberra, Australia, 2013.
Australian Technical Advisory Group on Immunisation (ATAGI). The Australian Immunisation Handbook, 9th edn. Australian Government Department of Health: Canberra, Australia, 2008.
Miller PDE, de Silva TI, Skinner R, Gilleece M, Peniket A, Hamblin A et al. Routine vaccination practice after adult and paediatric allogeneic haematopoietic stem cell transplant: a survey of UK NHS programmes. Bone Marrow Transplant 2017; 52: 775–777.
Zwar N, Hasan I, Harris M, Traynor V . Barriers and facilitators to influenza vaccination among high-risk groups aged less than 65 years-views from general practitioners and practice nurses. Aust N Z J Public Health 2007; 31: 558–561.
Lerchenfeldt SM, Cronin SM, Chandrasekar PH . Vaccination adherence in hematopoietic stem cell transplant patients: a pilot study on the impact of vaccination cards and reminder telephone calls. Transplant Infect Dis 2013; 15: 634–638.
Meiring J, de Silva TI, Snowden JA . A study of adherence to a vaccination schedule following adult allogeneic haematopoietic stem cell transplants in UK transplant centre. Bone Marrow Transplant 2015; 50 (Suppl 1): s203–s204.
Dombkowski KJ, Cowan AE, Reeves SL, Foley MR, Dempsey AF . The impacts of email reminder/recall on adolescent influenza vaccination. Vaccine 2017; 35: 3089–3095.
Doherty M, Schmidt-Ott R, Santos JI, Stanberry LR, Hofstetter AM, Rosenthal SL et al. Vaccination of special populations: protecting the vulnerable. Vaccine 2016; 34: 6681–6690.
Acknowledgements
BWT is kindly supported by the Peter MacCallum Cancer Centre Clinical Research fellowship.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Teh, B., Joyce, T., Slavin, M. et al. Impact of a dedicated post-transplant vaccination service at an Australian cancer centre. Bone Marrow Transplant 52, 1681–1683 (2017). https://doi.org/10.1038/bmt.2017.195
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2017.195